SCHEMBL4855320

SCHEMBL4855320

NC(CCCCNc1nc(Cl)nc(Nc2cc(S(=O)(=O)[O-])cc3cc(S(=O)(=O)[O-])c(N=Nc4ccccc4)c(O)c23)n1)C(=O)O.[Na+].[Na+]

nearest known ligand 0.48

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB known ✓ P10828 2/20 0.38
CA12 known ✓ O43570 4/20 0.35
CA1 known ✓ P00915 4/20 0.35
CA2 known ✓ P00918 4/20 0.35
P2RY4 known ✓ P51582 3/20 0.34
P2RY2 known ✓ P41231 2/20 0.33
P2RY6 known ✓ Q15077 2/20 0.33
P2RY12 known ✓ Q9H244 2/20 0.33
P2RY1 known ✓ P47900 1/20 0.32
FUT8 Q9BYC5 2/20 0.48
PRMT1 Q99873 3/20 0.42
CARM1 Q86X55 1/20 0.42
ENPP2 Q13822 2/20 0.40
APP P05067 1/20 0.39
MEN1 O00255 2/20 0.38
POLB P06746 2/20 0.38
KMT2A Q03164 2/20 0.38
GRK2 P25098 1/20 0.38
PLEC Q15149 1/20 0.38
USP2 O75604 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849250 0.94 ENPP2 (0.41) FUT8PRMT1CARM1ENPP2APP
SCHEMBL4855331 0.91 FUT8 (0.59) FUT8PRMT1CARM1ENPP2MEN1
SCHEMBL4855317 0.90 FUT8 (0.58) FUT8PRMT1CARM1ENPP2MEN1
SCHEMBL4849257 0.85 FUT8 (0.51) FUT8PRMT1ENPP2MEN1KMT2A
SCHEMBL14255277 0.85 FUT8 (0.51) FUT8PRMT1ENPP2MEN1KMT2A
SCHEMBL4849237 0.84 FUT8 (0.50) FUT8PRMT1ENPP2MEN1KMT2A
SCHEMBL29385758 0.84 FUT8 (0.56) FUT8PRMT1CARM1ENPP2APP
SCHEMBL6808069 0.84 FUT8 (0.56) FUT8PRMT1CARM1ENPP2APP
SCHEMBL29405634 0.78 PRMT1 (0.53) FUT8PRMT1CARM1ENPP2APP
SCHEMBL29663889 0.76 FUT8 (0.67) FUT8PRMT1CARM1ENPP2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7341604-B2 Highly affine cosmetic agent WELLA AG (DE) 2008-03-11 US disclosed
US-20060174423-A1 Highly affine cosmetic agent Wella GmbH (DE) 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060174423-A1 Highly affine cosmetic agent TYR, ENO1, CUTA THRB 3853/4885CA12 2216/4885CA1 3100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.